Summary The prognosis of colorectal cancer has not significantly changed during the last 30 years. While evaluation of tumour cell proliferation may provide prognostic information, results obtained so far have been contradictory. Heterogeneity in tumour cell proliferation may explain these contradictions. With in vivo injection of iododeoxyuridine (IdUrd), estimation of labelling index (LI), S-phase transit time (Ts) and potential doubling time (Tpot) may be performed from a single sample. A total of 109 colorectal cancers were studied after in vivo injection of IdUrd before surgical removal. From each cancer, four to eight samples were processed for both flow cytometrical (FCM) and immunohistochemical (IHC) visualization of IdUrd incorporation. Ll/IHC was morphometrically quantified at both the luminal border and the invasive margin of these tumours. LI was significantly higher at the luminal border compared with the invasive margin, although they were correlated with each other. Using combined IHC and FCM methods, rapidly growing colorectal cancers (high Li and/or low Tpot) showed an increased survival (significant for LI at the invasive margin and for 7pt at both the invasive margin and the luminal border) in the entire unselected material and for radically removed Dukes' B tumours. FCM data alone did not discriminate for survival, with the exception of T5 in diploid and radically removed Dukes' B tumours.
tumour cell proliferation might be correlated with poorer prognosis (Bauer et al, 1987; Harlow et al, 1991) .
Multiple parameters associated with tumour cell proliferation can be measured by in vivo injection of bromo-(BrdUrd) or iododeoxyuridine (IdUrd), and dual-parameter flow cytometric analysis of a single sample (Begg et al, 1985) . This technique allows determination of labelling index (LI), the duration of Sphase (T") and potential doubling time (T 0t) in colorectal cancer (Rew et al, 1991; Wilson et al, 1993a and b; Terry et al, 1995) . LI can be evaluated either by FCM of cell suspensions or by morphometry in immunohistochemically (IHC) stained tissue sections. T can thus be calculated with LI derived either from histology or from FCM (Bennett et al, 1992) . The findings by Dische and Saunders (1989) , Rew et al (1991) and Wilson (1991) suggest that cell proliferation evaluated with this technique might be of independent prognostic value.
Colorectal cancer show a marked intratumoral heterogeneity with respect to several parameters, such as DNA content (Koha et al, 1990 ) and histological differentiation (Jass et al, 1986) , and to proliferative parameters, such as S-phase fraction (Lindmark et al, 1991) , PCNA (Teixeira et al, 1994) and expression of Ki-67 (Shepherd et al, 1988) . Wilson et al (1993b) used flow cytometry alone to measure T , and have also described intratumoral heteropot geneity in colorectal cancers. In addition, Taniyama et al (1993) have reported that mainly moderately differentiated colorectal cancer can be poorly differentiated at the invasive margin and that such tumour regions can also differ with respect to proliferative activity and tumour spread.
The aim of this study was (1) to evaluate whether there is a systematic heterogeneity with respect to cell proliferation between deep (invasive margin) and superficial (luminal border) parts of colorectal cancers and (2) to investigate the prognostic impact of LI, T and Tpt.
MATERIAL AND METHODS Patients
One hundred and nine patients with colorectal cancer who underwent surgery at the University Hospital of Ume'a (71 patients) and at the district hospitals of Ornskoldsvik (13), Lycksele (9), Pite'a (10) and Lule'a (6) within the northern healthcare region of Sweden were prospectively included in the study. After hospital ethical committee approval, informed consent was obtained from the patients. Intravenous infusion of a single dose of 100 mg of IdUrd dissolved in 100 ml of 0.9% saline was given at a median of 5.2 h (range 1.1-8.9 h) before surgery. At the University Hospital of Ume'a, fresh unfixed tumours were transported immediately after removal to the Department of Clinical Pathology for further processing. Each tumour was systematically sampled by dividing the tumour into equal numbers of central and peripheral regions, with at least four regions in total. From each of these regions, adjacent samples were taken for routine histological evaluation, morphometric analysis of LI in IHC-stained tissue sections and for flow cytometric analysis of cell kinetic relations, i.e. LI, T and T ot (Figure 1 All follow-up data were obtained by AO. The follow-up time of living patients ranged from 18 to 78 months, with a median of 37 months. To verify the accuracy of cancer-specific survival used in this study, curves of cancer-specific survival for the entire material (n = 109) were compared with relative survival data, i.e. death rates of the colorectal cancer group compared with death rates of a corresponding normal population. The two survival curves showed good agreement. In addition, the survival curve for the group of patients treated at the district hospitals corresponded well with the survival curve from patients treated at the University Hospital of Ume'a.
Flow cytometric analysis of IdUrd nuclear incorporation
The rod-shaped tissue samples of size 3-5 x 3-5 x 10-20 mm, taken for FCM analyses from each colorectal carcinoma, were immediately fixed in 70% ethanol and then stored at 4°C until analysis. Before FCM processing, one piece of tissue from each of these specimens was minced into smaller pieces, subsequently digested using 0.4 mg ml-' pepsin (Sigma Chemical, St Louis, MO, USA) in 0.1 M hydrochloric acid at 37°C for 30 min during continuous agitation and filtered through a 50-gm nylon mesh (Nylander et al, 1994) . The concentration of nuclei was adjusted to 2 x 106 ml-' and the solution centrifuged for 5 min at 2000 r.p.m. to sediment the nuclei. The resulting nuclear pellet was partly denatured in 2 ml of 2 M hydrochloric acid for 15 min. The denaturation process was stopped by addition of 2.5 ml of borax (JT Baker Chemical, Phillipsburg, NJ, USA) in 2.5 ml of phosphate-buffered saline (PBS) added with 0.5% Tween 20 (Sigma Chemical). After a wash in PBS, the cell suspension was incubated at room temperature for 30 min with a BrdUrd/IdUrd monoclonal antibody diluted 1:20 (Dakopatts, Denmark), washed in PBS and incubated with fluorescein isothiocyanate-(FITC) conjugated rabbit anti-mouse F(ab)2 fragment (F3 13, Dako) (1:50 dilution) for 30 min at room temperature. After a final wash in PBS, the pellet was resuspended in a propidium iodide solution containing RNAase and left in the dark at 4°C for at least 30 min before analysis. The suspensions were analysed on a FACScan flow cytometer (Becton Dickinson) using the FACScan or LYSYS software (Becton Dickinson). Debris, damaged cells and doublets were excluded by gating on a forwardand side-scatter dot plot and on the FL2 width and FL2 area dot plot.
The analysis was performed so that the G, diploid peak was situated near channel 200, with a tetraploid peak around 400. Normal colorectal mucosa specimens from each patient were used as an internal control. With ethanol-fixed material, as used in this study, multipeak profiles were rare, and ploidy analysis using special software algorithms was not necessary. From each specimen, 10 000 cells or more were analysed for Ts, LI/FCM and Tp)/FCM. LI/FCM and T /FCM were calculated as suggested by Steel (1977) , when X pot was assumed to be 0.8 according to Wilson and McNally (1992) . Correction of LI/FCM for mitotic division from time of infusion with IdUrd and to time for fixation was made according to a technique described by Lochrin et al (1992) . According to the DNA histogram calculation, the DNA index was determined and, if one or more samples from the same tumour were found to be aneploid, that tumour was classified as aneuploid. In aneuploid tumours, LI/FCM analyses was restricted to the aneuploid cell population. The CV (coefficient of variation) of the DNA peaks for diploid cells in aneuploid tumours had a mean value of 6.3 (range 2.8-10.6). The DNA peaks of aneuploid tumour cells had a mean CV of 7.1 (2.9-12.4).
Immunohistochemical procedures
For histopathological analysis, a tumour sample cut perpendicular to the mucosal surface was collected from each region (see above), fixed overnight in 10% formalin buffered to neutrality with phosphate buffer and subsequently embedded in paraffin. The sample included a section from the entire tumour, i.e. from the intestinal lumen all the way to the submucosa, muscular layer or to the t(h peripheral fat. Four-micrometre sections were cut from the paraffin blocks (four from each tumour) and left to dry overnight at 37°C (Nylander et al, 1994) , followed by 30 min at 56°C. After dewaxing and rehydration, the slides were digested with 0.4% pepsin in 0.01 M hydrochloric acid at 370C for 30 min, followed by 2 M hydrochloric acid treatment at room temperature for 20 min. After rinsing in PBS, the slides were stained in an automated immunostainer (Ventana ES, Ventana, Tucson, AZ, USA) using an anti-IdUrd/BrdUrd monoclonal antibody (BrdU, Becton Dickinson) at a dilution of 1:600. Antibody visualization was performed according to the Ventana program. The slides were then manually counterstained with Mayer's haematoxylin for 1.5 min. The Ventana ES is constrained to perform all incubations at a 400C slide reaction temperature.
Morphometrical analysis
One IHC-stained section from each of the four tissue samples (collected as described above) was used for morphometric analysis. A Zeiss microscope (63 x objective magnification) equipped with a square lattice in the eyepiece was used to define the proper size of the counting frame in each of the tumours evaluated (Gundersen et al, 1988) . From each tumour about 40 fields of vision were measured in a systematic random fashion, so that the first field was selected at random while subsequent fields were chosen systematically by adjusting the distance between individual fields of vision roughly proportional to the overall area in question. Two tumour compartments were regularly evaluated in each section. One was represented by the most superficial fourth (corresponding to the luminal tumour part), while the other was represented by the deepest fourth (corresponding to the invasive margin) (Figure 2 ). The two compartments were analysed separately without prior knowledge of the results from earlier morphometrical evaluations.
Two unbiased counting frames (Gundersen, 1977) were chosen within each of the 40 fields of vision. One of these frames was used to count positive nuclei and the other to count negative nuclei. These counts were then used to calculate the numerical density of positive and negative nuclei. The labelling index was calculated as:
where Qp is the number of positive nuclei, Ap is the area of the counting frame used to count positive nuclei, Q. is the number of negative nuclei and A is the frame area used for counting the negative nuclei. Only epithelial tumour nuclei were examined.
For each tumour, about 200 positive and 200 negative nuclei were counted from both the most superficial (luminal border) and the deepest (invasive margin) fourths. In practice, the intratumoral coefficient of error (CE) of the numerical density for positive nuclei for each defined tumour compartment (e.g. invasive margin) was between 0.05 and 0.15. The technique of Lochrin et al (1992) was used to correct LI for mitotic division from time of infusion with IdUrd to time of fixation.
With these procedures, LI was quantitatively evaluated as a mean value for the entire tumour, using FCM analysis of nuclear suspensions, and as an index for both luminal border (most superficial fourth) and invasive margin (deepest fourth) in immunohistochemically stained sections from each tumour. TPO /IHC was calculated according to Bennet et al (1992) , using LI from either the invasive margin or the luminal border:
Reliability of quantitative results from morphometrical methods (Gundersen and Osterby, 1981; Gundersen and Jensen, 1987) depends on uniform sampling at all levels from a random systematic approach, however, in clinicopathological practice, such a procedure is not always possible to achieve. In this study, all sampling steps were performed in a uniform way, with the exception of the first step when a strict systematic sampling was used. We therefore tested our sampling error in measuring LIIIHC using four tumours that were sampled according to a strictly systematic scheme and to a morphometrically correct random systematic scheme. The comparison between the two sampling procedures showed only a minor sampling error, with a CE for the difference between the paired tumour samples of 0.04.
Statistics
Spearmans correlation coefficient (r) and Wilcoxon matched-pairs signed-rank test were used to compare sets of parameters measured on the same tumour. To compare distributions of a variable for groups, the Kruskal-Wallis test was used. For morphometrical analysis, CE was calculated according to methods described by West et al (1990) . Kaplan-Meier's method was used to estimate the cancer-specific survival, and comparison between groups was performed using the log-rank test. Death with known locoregional or distant metastases was processed as an event and, if no event occurred, the patient was censored at the time of the last clinical follow-up. A P-value less than 0.05 was considered to be statistically significant. The median value or the highest/lowest quartiles of the entire patient material were used as cut-off points to create groups for comparison of different parameters. Statistical analyses were performed using SPSS version 6.1.3 (SPSS, IL, USA).
RESULTS
Of the 109 colorectal cancers, 89 could be evaluated with flow cytometry while 97 were analysed morphometrically. Of these, the invasive margin could be evaluated in 97 and the luminal border in 94 of the cancers. All tumours in which light microscopic shortcomings prevented identification of the luminal border and/or the invasive margin, and/or measurement of the distance between the luminal border and the invasive margin were excluded. At least British Joumal of Cancer (1998) 77(6) (Figures 3 and 4) . Only nine tumours showed higher LI at the invasive margin. Nevertheless, LIIIHC at the luminal border and the invasive margin were correlated to each other (r = 0.66, P < 0.001; Figure 5 ). No significant correlations were found for LI/IHC and Dukes' stage, grade or topography. Furthermore, no significant difference was observed between central and peripheral samples regarding LI/FCM, either for Ts or for TPOt/FCM (P = 0.3, P = 0.8 and P = 0.7 respectively). As expected, stage according to Dukes was a strong prognostic indicator P < 0.001 (Figure 6 ). For the entire unselected tumour material, colorectal cancers with low LI/IHC (below median value) at the invasive margin tended to have poorer prognosis than those with high LI/IHC. Tumours with very low LI/IHC at the invasive margin (lowest quartile used as cut-off level) showed significantly lower survivals (P = 0.02, Figure 7A ). In radically removed tumours, very low LI/IHC (lower quartile as cut-off level) was associated with significantly lower survival rates than those with higher LI/IHC. These results were generally valid for all radically removed tumours (P = 0.01) and for radically removed Dukes' B tumours (P = 0.01), although a small number of tumours with low LI/IHC were recorded in the Dukes' B group ( Figure 7B ). No differences in survival were seen in the Dukes' C group. The survival pattern for LI/IHC at the luminal border was Radically removed tumours in which the difference in the magnitude of LIAIHC between the luminal border and the invasive margin was large tended to have a favourable prognosis, although this trend was not statistically significant (P = 0.07) when using the lowest quartile as cut-off level. The difference in LI/IHC between the luminal border and the invasive margin did not prognostically discriminate patients with radically removed Dukes' B tumours.
T, and Tt T AfIHC at the invasive margin significantly predicted survival.
Patients with very long T,/1IHC at the invasive margin (highest quartile as cut-off level) had significantly lower survival rates both in the entire unselected tumour material (P = 0.002, Figure 8A ) and in the group with radically removed Dukes' B colorectal cancers (P < 0.001, Figure 8B cut-off point, although this was restricted to the group with radically removed Dukes' B colorectal cancers, and the significance level was lower (P = 0.04). Using the highest quartile as the cut-off level, TPOt/IHC at the luminal border significantly predicted survival in the entire unselected material and for patients with radically removed Dukes'B tumours (P = 0.008 and P = 0.002 respectively). However, when the median value was used as the cut-off level, T ,t/IHC at the luminal border did not significantly predict survival.
Tpot analysed by flow cytometry alone did not discriminate for survival, either generally or for radically removed Dukes' B tumours. A borderline P-value was recorded for the entire unselected material with the highest quartile as cut-off level (P = 0.05). No survival discrimination was found either for overall radically removed tumours or for radically removed Dukes' B tumours. T did not discriminate for survival, with the exception of radically removed Dukes' B tumours, when the upper quartile was used as the cut-off level (P = 0.04).
DNA ploidy
Thirty-nine of the 90 flow cytometrically evaluated tumours were diploid while the remaining 51 were classified as aneuploid. LI/FCM was significantly (P = 0.001) lower for diploid than for aneuploid colorectal cancers (Table 1 ). In contrast, significantly (P = 0.04) higher values of LI/IHC were observed at the invasive margin for diploid compared with aneuploid cancers. Diploid and aneuploid tumours did not differ for LI/IHC at the luminal border. The magnitudes of the calculated absolute differences between LI/IHC at the luminal border and at the invasive margin were significantly higher in aneuploid than in diploid tumours (P = 0.001, Table 1 ).
British Journal of Cancer (1998) 77(6) (7.6-11.0) (14.9-19.8) (10.7-14.7) (6.0-9.6) (7.4-9.6) (3.2-5.5) (1.6-2.9) (2.5-4.8) TP,/fcm, potential doubling time measured with flow cytometry alone. *P < 0.05 between groups of the same proliferative-associated parameter. **P < 0.01 between groups of the same proliferative-associated parameter. Numbers within brackets represent 95% confidence intervals of the mean. aLI/fcm from right colon was significantly lower than values from both left colon and rectum.
Concerning survival, no prognostic information was seen for ploidy itself, either in the total unselected material (P = 0.8) or in the group of radically removed tumours (P = 0.6). With one exception (see below), the prediction of survival from parameters associated with cell proliferation (LI, T, T ), regardless of method of evaluation (IHC and/or FCM), was not improved by taking ploidy into account. This was valid for the entire material and for the group with radically removed tumours. Survival analyses were not carried out for the different Dukes' stages in combination with ploidy status because of the small number of observations in the respective groups. The exception was observed for patients with diploid tumours showing very long T7 (highest quartile used as cutoff level). These patients had a higher mortality rate than those with shorter Ts-values (P < 0.001 for both the entire material and radically removed tumours). No significant difference in survival was observed for T' when studying the group of aneuploid tumours.
Clinicopathological parameters
With the exception of sex, topography and ploidy, none of the clinicopathological parameters covaried with parameters associated with proliferation (Table 1) . LI/HIC at both the invasive margin and the luminal border showed significant differences between the sexes; where women had higher LIs than men (P = 0.02 and P = 0.02 respectively). Colorectal cancers in female patients had significantly lower values of T A/IHC at the invasive margin compared with colorectal cancers in men (P = 0.049). LI/FCM was also significantly lower in tumours derived from the right colon compared with the left colon and rectum. In contrast, LIIIHC did not differ according to topography for the invasive margin or for the luminal border.
DISCUSSION
The morphometric procedure used in this study is well known and has been evaluated theoretically (Weibel, 1979) . The technique basically assumes a random, systematic sampling procedure and focuses on counting a defined number of nuclei to provide a reliable mean value from each tumour (Gundersen et al, 1988; West and Gundersen, 1990) . The comparative test performed in our laboratory, in which our standard non-random procedure of sampling was compared with an optimal random systematic Systematic heterogeneity in colorectal cancer 923 sampling, gave an excellent correlation, indicating that the results obtained in this study were not significantly influenced by the sampling procedure used. The definition of tumour compartments corresponding to the invasive margin and to the luminal border was done for practical reasons to standardize the morphometric procedure.
Presence of heterogeneity is well known for many solid tumours, including colorectal carcinomas. In this respect, the most extensive studies concern DNA analyses, i.e. evaluation of ploidy (Hiddemann et al, 1986; Scott et al, 1987) and S-phase fraction (Quirke et al, 1985; Lindmark et al, 1991) , but also to other proliferative parameters such as PCNA (Teixeira et al, 1994) and expression of Ki-67 (Shepherd et al, 1988) . A few reports exist on the presence of intratumoral heterogeneity with respect to LI/IHC and T /IHC in renal cell carcinoma (Larsson et al, 1994) and to pot T /FCM in colorectal cancer (Wilson et al, 1993b) . Our study pot describes the existence of a systematic heterogeneity within colorectal cancer with more pronounced LI at the luminal border compared with the invasive margin for a majority of colorectal cancers. Such a proliferative difference in colorectal cancer is supported by reports after in vitro labelling (LI/IHC) with BrdUrd (Taniyama et al, 1993) and by distribution of Ki-67 tumour cell LI combined with endothelial cell proliferative heterogeneity (Vermeulen et al, 1995) .
Evaluation of proliferation with FCM after in vivo incorporation of IdUrd does not in practice allow the different defined tumour compartments to be analysed separately. In addition, it is difficult to distinguish between tumour and non-tumour cells, at least in diploid tumours, because of the admixture of normal, less proliferative cells . The more reliable measurements of LI with IHC suggest that LI at the invasive margin is, in comparison with LI/FCM, rather the reverse, with higher LI in diploid than in aneuploid tumours. In contrast, when analysing the LI/IHC at the luminal border, no difference between diploid and aneuploid tumours was observed. Speculatively, there are two possible major explanations for the difference in proliferation between the luminal border and the invasive margin, although these explanations are not mutually exclusive.
On the one hand, feacal content is known to stimulate cell proliferation and, therefore it seems reasonable that the proliferation rate would be higher at the luminal border and that the proliferative activity would decrease when the diffusion distance from the feacal factors increases. Such proliferative stimulators are, for example, secondary bile acids, mainly lithocholic acid, other steroid-derived compounds, short-chain fatty acids and the direct influence from the bacterial content (Mullan et al, 1990) . However, local non-specific regenerative factors from the ulcerative process at the luminal border can also increase the luminal proliferative activity.
On the other hand, tumour cells growing at the invasive margin might be more influenced by factors produced by the surrounding stromal cells rather than by cells at the luminal border. Such an influence includes differences in local levels of growth factors, e.g. transforming growth factor beta (TGF-P). TGF-P has several diverse fields of action in normal cells, eg. decreasing proliferation, increasing differentiation, increasing apoptosis and stimulating angiogenesis (Lawrence et al, 1996) . The correlation between decreased proliferation and a higher mortality rate observed in this study could be in accordance with some of the effects of TGF-P. The total action of TGF-P is, however, highly complex and not completely understood. Other factors affecting proliferation of tumour cells are also released from the stromal cells and some of them are known to interfere with the cell cycle. This suggests a possible mechanism for the decreased proliferative activity at the invasive margin.
Tumour cells with invading behaviour require high rates of protein synthesis but are not dependent on DNA synthesis and proliferation (Thorgeirsson et al, 1984) . In addition, in malignant gliomas, it is believed that tumour cells must cease proliferation to be able to invade the surrounding tissue (Pilkington et al, 1992) . The extracellular matrix proteins seem to inhibit the proliferation of glioma cells and instead stimulate them to migrate (Koochekpour et al, 1995) . In addition to these two possible explanations, the presence of separate cell clones at the luminal border and at the invasive margin, and problems of nutrient and oxygen delivery to the invasive margin cannot be excluded.
The systematic heterogeneity observed in this study has implications for sampling when cell kinetic parameters are to be evaluated. As LIs at the luminal border and invasive margin are well correlated, cell kinetic evaluation of samples taken regularly from either of these compartments seems rational. Analyses of randomly extracted samples from colorectal cancers may, however, be of less value.
The prognostic impact of cell kinetic data in colorectal cancer remains questionable. Concerning S-phase fraction, results both with (Bauer et al, 1987; Witzig et al, 1991) and without (Enker et al, 1991) significant prognostic impact have been published; Therefore, according to the consensus by Bauer et al (1993) doubts remain as to whether the S-phase fraction can contribute to the prediction of outcome for patients with colorectal cancer. Cell kinetic studies of colorectal carcinoma using other cell cycle associated parameters are sparse. Rew et al (1993) studied colorectal cancer after in vivo incorporation of BrdUrd and did not find any prognostic impact of flow cytometric evaluation of TPot. Morphometric analysis of Ki-67 after immunohistochemical staining of routinely fixed, paraffinembedded tumour samples (Kubota et al, 1992; Baretton et al, 1996) also failed to predict the outcome.
In contrast to previous reports, our data indicate a negative influence from cell proliferation after IdUrd incorporation in vivo, significant for LI/IHC and T /IHC in the unselected group of colorectal cancers. One conceivable explanation for the observed impact on prognosis could be the morphometric control of the systematic heterogeneity that exists between the luminal compartment and the invasive margin in our study (extensively discussed by Rew et al (1993) . The negative prognostic impact from cell proliferation after in vivo incorporation of IdUrd observed in this study, i.e. shorter survival for colorectal cancer with a low LI or long Tpt compared with tumours with high LI and short T,t, has to the best of our knowledge not been reported earlier. However, morphometrical evaluation of PCNA in a group of advanced colorectal cancers also showed a correlation between low PCNA LI/IHC and poorer prognosis (Paradiso et al, 1996) . Decreased cell proliferation corresponding to lower LIIIHC after in vitro incorporation of BrdUrd in diploid colorectal cancers has previously been correlated with increased numbers of regional lymph node metastases (Taniyama et al, 1993) . Furthermore, low LI/IHC for PCNA and Ki-67 correlate to areas with low differentiation at the invasive margin of colorectal cancer (Taniyama et al, 1996) . A recent study of cell proliferation in breast cancer also indicates a connection between positive survival outcomes after treatment and high LI/IHC after BrdUrd incorporation (Gamel et al, 1995) .
This study provides new insight into the biological behaviour of colorectal cancer. Therefore, additional studies with IdUrdlBrdUrd and other cell cycle-associated parameters, such as Ki-67, are important, provided that the problem of heterogeneity is taken into account.
